Genpact (NYSE:G – Get Free Report) had its target price hoisted by analysts at Susquehanna from $40.00 to $42.00 in a research report issued to clients and investors on Friday, Benzinga reports. The firm presently has a “neutral” rating on the business services provider’s stock. Susquehanna‘s price target points to a potential upside of 2.04% from the stock’s previous close.
Other equities research analysts also recently issued research reports about the company. BMO Capital Markets restated a “market perform” rating and issued a $40.00 target price on shares of Genpact in a research report on Friday, August 7th. Wall Street Zen upgraded Genpact from a “hold” rating to a “buy” rating in a report on Saturday, October 3rd. Deutsche Bank Aktiengesellschaft set a $31.00 price objective on Genpact in a research report on Friday, July 10th. Citigroup boosted their price objective on shares of Genpact from $32.00 to $36.00 and gave the company a “neutral” rating in a report on Friday, August 7th. Finally, TD Cowen upped their target price on shares of Genpact from $42.00 to $43.00 and gave the company a “buy” rating in a research report on Friday, August 7th. Two investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $41.00.
Read Our Latest Stock Report on Genpact
Genpact Price Performance
Genpact (NYSE:G – Get Free Report) last released its quarterly earnings data on Thursday, November 5th. The business services provider reported $1.07 EPS for the quarter, beating analysts’ consensus estimates of $1.04 by $0.03. Genpact had a return on equity of 23.34% and a net margin of 11.04%. The firm had revenue of $1.39 billion for the quarter, compared to analysts’ expectations of $1.38 billion. During the same period in the prior year, the firm posted $0.97 earnings per share. The firm’s quarterly revenue was up 7.3% on a year-over-year basis. Sell-side analysts anticipate that Genpact will post 3.66 earnings per share for the current year.
Insider Buying and Selling
In other Genpact news, SVP Anil Nanduru sold 6,191 shares of the company’s stock in a transaction on Wednesday, August 19th. The stock was sold at an average price of $37.03, for a total transaction of $229,252.73. Following the transaction, the senior vice president directly owned 70,253 shares in the company, valued at $2,601,468.59. This represents a 8.10% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 1.58% of the stock is owned by company insiders.
Institutional Investors Weigh In On Genpact
Several institutional investors and hedge funds have recently modified their holdings of G. Fifth Third Bancorp boosted its holdings in Genpact by 8.8% in the first quarter. Fifth Third Bancorp now owns 3,691 shares of the business services provider’s stock valued at $137,000 after purchasing an additional 300 shares during the period. Basecamp Wealth Advisors LLC grew its stake in Genpact by 54.7% during the 1st quarter. Basecamp Wealth Advisors LLC now owns 1,046 shares of the business services provider’s stock worth $39,000 after purchasing an additional 370 shares in the last quarter. Walled Lake Planning & Wealth Management LLC grew its stake in Genpact by 0.4% during the 3rd quarter. Walled Lake Planning & Wealth Management LLC now owns 103,891 shares of the business services provider’s stock worth $3,380,000 after purchasing an additional 406 shares in the last quarter. Flynn Zito Capital Management LLC increased its holdings in Genpact by 4.8% during the 3rd quarter. Flynn Zito Capital Management LLC now owns 8,910 shares of the business services provider’s stock worth $290,000 after purchasing an additional 408 shares during the period. Finally, Janney Montgomery Scott LLC increased its holdings in Genpact by 2.4% during the 1st quarter. Janney Montgomery Scott LLC now owns 17,309 shares of the business services provider’s stock worth $645,000 after purchasing an additional 410 shares during the period. Hedge funds and other institutional investors own 96.03% of the company’s stock.
Key Stories Impacting Genpact
Here are the key news stories impacting Genpact this week:
- Positive Sentiment: Genpact reported third-quarter adjusted earnings of $1.07 per share, ahead of estimates of $1.04–$1.05. Revenue was $1.39 billion, up 7.3% year over year and slightly above expectations. Genpact Q3 Earnings and Revenues Top Estimates
- Positive Sentiment: Advanced Technology Solutions revenue grew 30% year over year, supporting the quarter’s performance. Genpact also raised its 2026 guidance for gross margin and adjusted diluted EPS, signaling confidence in profitability. Genpact Reports Third Quarter 2026 Results
- Positive Sentiment: Needham & Company raised its price target to $55 from $45 and maintained a Buy rating. The new target represents about 33.6% upside from the cited $41.16 reference price. Needham & Company recommendations
Genpact Company Profile
Genpact (NYSE: G) is a global professional services and business process management company that helps organizations improve operations through digital transformation, data and analytics, artificial intelligence, and industry-specific expertise. The company combines technology with operational services to support clients across core business functions.
Its offerings include finance and accounting, procurement, supply chain management, customer experience, risk and compliance, insurance operations, and banking and capital markets services.
Further Reading
- Five stocks we like better than Genpact
- These 3 Underperforming Stocks Are Seeing Notable CEO Insider Trades
- GE Aerospace Has a $170 Billion Backlog, But Is the Stock Worth the Premium?
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.
